Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London · Delayed Price · Currency is GBP · Price in GBX 345.00
+25.00 (7.81%)
Aug 28, 2025, 5:15 PM BST
Hemogenyx Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
16.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| ConvaTec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Oxford Nanopore Technologies | 183.19M |
Hemogenyx Pharmaceuticals News
- 2 days ago - Hemogenyx raises £570,000 and Director's Dealing - Accesswire
- 13 days ago - Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy - Accesswire
- 4 weeks ago - Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £250,000 and Director's Dealing - Accesswire
- 6 weeks ago - Hemogenyx Awarded Grant - Accesswire
- 2 months ago - Hemogenyx Pharmaceuticals PLC Announces Clearance to Proceed with Pediatric Expansion - Accesswire
- 3 months ago - Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing - Accesswire
- 3 months ago - Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests - Accesswire
- 3 months ago - Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol - Accesswire